Looking at options history for Regeneron Pharmaceuticals REGN we detected 8 trades. If we consider the specifics of each ...
Regeneron and Sanofi's Dupixent sBLA for treating chronic spontaneous urticaria in patients 12+ gets FDA review, with a ...
The FDA has provided a date of April 18, 2025, to review the application for Dupixent to treat patients with chronic ...
The FDA last year turned away the companies' application and asked for additional efficacy data. Regeneron and Sanofi said the resubmission adds results from an additional Phase 3 study of Dupixent in ...
The FDA has accepted Sanofi and Regeneron’s application to expand Dupixent’s use, with a decision expected by April 2025.
Set just over 10,000 years before Paul Atreides’ birth, Prophecy revolves around sisters Valya (Emily Watson) and Tula ...
Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...